Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Of all the tests commonly used to diagnose syncopal episodes in older patients, postural blood pressure testing is the one most likely to…
Heather L. Gornik, MD, MHS, Director Noninvasive Vascular Laboratory Cleveland Clinic, discusses the treatment of FMD or fibromuscular dysplasia, which depends on the vascular beds involved and the…
NEW YORK (Reuters Health) – The results of a 30-year study indicate that intensive glucose control can substantially reduce the rates of retinopathy, nephropathy, and cardiovascular disease in…
NEW YORK (Reuters Health) – In patients with pulmonary thromboemboli, the presence of a mobile right cardiac thrombus (MRCT) is strongly linked to death, new research shows. Although…
NEW YORK (Reuters Health) – In the general population of patients with elevated blood pressure, there is currently no evidence to support aiming for a blood pressure (BP)…
NEW YORK (Reuters Health) – In a study of a busy coronary care unit in Kuwait, 41.1% of patients treated with unfractionated heparin for 6 hours had a…
NEW YORK (Reuters Health) – Compared with a strategy of optimal medical therapy alone for treatment of stable coronary artery disease (CAD), the addition of percutaneous coronary intervention…
NEW YORK (Reuters Health) – Adherence to a healthy diet and lifestyle can reduce the lifetime risk of heart failure and the risk of incident hypertension, according to…
NEW YORK (Reuters Health) – Pitavastatin is equivalent to atorvastatin in its ability to reduce coronary plaque volume in patients with acute coronary syndrome (ACS), Japanese researchers have…
NEW YORK (Reuters Health) – Intracoronary nicardipine before elective percutaneous coronary intervention (PCI) does not reduce post-treatment cardiac enzyme leakage in low-risk patients, new research shows. Prior research…
